Why the study?
The study aimed to investigate the usefulness of the fibrinogen-to-albumin ratio as a prognostic marker in patients admitted to an ICU compared with the SOFA score.
Does a high fibrinogen-to-albumin ratio predict 1-year mortality in patients admitted to an intensive care unit?
Does a high fibrinogen-to-albumin ratio predict 1-year mortality in patients admitted to an intensive care unit?
Answers are grounded in this paper and cite their sources.
Fibrinogen-to-albumin ratio at ICU admission is a feasible prognostic marker for 1-year mortality, performing similarly to the more complex SOFA score.
The objective of this study was to investigate the usefulness of fibrinogen-to-albumin ratio (FAR) as a prognostic marker in patients admitted to an intensive care unit (ICU) compared with Sequential Organ Failure Assessment (SOFA) score, a widely used prognostic scoring system. An inverse probability weighting (IPW) was used to control for selection bias and confounding factors. After IPW adjustment, the high FAR group showed significantly higher risk of 1-year compared with low FAR group (36.4% vs. 12.4%, adjust hazard ratio = 1.72; 95% confidence interval (CI): 1.59–1.86; p < 0.001). In the receiver-operating characteristic curve analysis associated with the prediction of 1-year mortality, there was no significant difference between the area under the curve of FAR on ICU admission (C-statistic: 0.684, 95% CI: 0.673–0.694) and that of SOFA score on ICU admission (C-statistic: 0.679, 95% CI: 0.669–0.688) (p = 0.532). In this study, FAR and SOFA score at ICU admission were associated with 1-year mortality in patients admitted to an ICU. Especially, FAR was easier to obtain in critically ill patients than SOFA score. Therefore, FAR is feasible and might help predict long-term mortality in these patients.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: